Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Private equity fund managers are focusing on value creation amid economic uncertainty. The growing consensus is that they no ...

Apple reimaged technology, made it easy to use, and created a revolutionary culture. From the Mac to the iPhone Apple ...

Nutanix sits at an inflection point as VMware customers migrate; SaaS growth, rising profits, buybacks, and AI upside support ...

The study found that once hitting the 100K point, impressions no longer increase in a linear fashion. Instead, that reach ...

Every Friday, our deals experts set aside their usual affinities for finding discounts to search the web for the week’s best ...

Attending meetings like the SGO Annual Meeting on Women's Cancer is driven by a shared commitment to patients and advancing ...

The cycle of disengagement will continue to repeat, no matter how advanced the tools or how sophisticated the strategies ...

Researchers built an immune-aging clock from 1.2 million cells, revealing T cells as key indicators of immune aging. They ...

Cosnova ran 15 different pilots to find out what works for the marketing function when it comes to AI – and what does not – ...

We love The Pitt because it's giving us what we want out of television.

As regulations evolve and AI takes a larger role in hiring, companies need to be intentional about developing responsible AI ...